This inventor holds 2 USPTO granted patents. Top assignees: Three Rivers Pharmacueticals, LLC, University System of Maryland. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2009-2012
Title: Larry Augsburger: Innovator in Pharmaceutical Dosage Forms
Introduction
Larry Augsburger is a notable inventor based in Severna Park, MD (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative dosage forms. With a total of 2 patents, his work focuses on enhancing the efficacy and usability of pharmaceutical products.
Latest Patents
Augsburger's latest patents include "Methods for making pharmaceutical dosage forms containing active cushioning components" and "Composition containing ribavirin and use thereof." The first patent describes novel methods for creating dosage forms that can be compressed while maintaining uniform composition and robustness, which also exhibit reduced friability. Additionally, it relates to methods for producing fast-disintegrating dosage forms. The second patent discloses ribavirin formulations suitable for capsules or tablets, along with processes for their preparation and administration.
Career Highlights
Throughout his career, Larry Augsburger has worked with esteemed organizations such as the University System of Maryland and Three Rivers Pharmaceuticals, LLC. His experience in these institutions has allowed him to advance his research and contribute to the pharmaceutical industry significantly.
Collaborations
Augsburger has collaborated with notable colleagues, including John R. Bergeron and Ngoc Do. Their combined expertise has further enriched the research and development of innovative pharmaceutical solutions.
Conclusion
Larry Augsburger's contributions to pharmaceutical dosage forms demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of the complexities involved in drug formulation and delivery. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile